Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Juniper Biomedical has completed over 20 preclinical studies and refined its implant through hundreds of prototypes. The technology is now in the clinical design phase, with an early feasibility study underway to refine procedures and stimulation paradigms. The company recently won the NIH Neuromod Prize Phase 2 competition and closed an oversubscribed seed funding round, validating its approach to targeted pelvic nerve stimulation for improved outcomes in mixed urinary incontinence and other pelvic health conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juniper Biomedical.